EDITORIAL
Accepted on 11 Nov 2025
Editorial: The Application of Immune Checkpoint Inhibitors Combined with Chemotherapy in Tumor Immunotherapy
- 122 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- The Application of Immune Checkpoint Inhibitors Combined with Chemotherapy in Tumor Immunotherapy
The Application of Immune Checkpoint Inhibitors Combined with Chemotherapy in Tumor Immunotherapy
10k
Total downloads
49k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 13 Aug 2025
Efficacy and safety of first-line chemotherapy combined with immune checkpoint inhibitors for extensive-stage small cell lung cancer patients: a real-world propensity score matching study
doi 10.3389/fimmu.2025.1562458
- 1,782 views
ORIGINAL RESEARCH
Published on 18 Jul 2025
Development and validation of nomogram for predicting pathological complete response to neoadjuvant chemotherapy and immunotherapy for locally advanced gastric cancer: a multicenter real-world study in China
doi 10.3389/fimmu.2025.1603196
- 1,937 views
CASE REPORT
Published on 30 Jun 2025
Cadonilimab combined with trastuzumab and chemotherapy for HER2-positive gastric cancer with bone marrow metastasis and DIC: a case report and literature review
doi 10.3389/fimmu.2025.1608636
- 3,288 views
- 1 citation
CASE REPORT
Published on 30 Jun 2025
Long-term survival in advanced pulmonary large-cell neuroendocrine carcinoma after multi-line immunochemotherapy and anti-angiogenic therapy: a case report
doi 10.3389/fimmu.2025.1618672
- 2,362 views
- 2 citations
CASE REPORT
Published on 26 Jun 2025
Durable immunotherapeutic response in molecularly complex pulmonary adenosquamous carcinoma: case report and literature review
doi 10.3389/fimmu.2025.1614283
- 2,317 views
ORIGINAL RESEARCH
Published on 20 Jun 2025
Total neoadjuvant immunochemotherapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer
doi 10.3389/fimmu.2025.1611386
- 1,926 views
ORIGINAL RESEARCH
Published on 20 May 2025
B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer
doi 10.3389/fimmu.2025.1553042
- 2,985 views
CASE REPORT
Published on 01 May 2025
Complete remission of a high-risk, locally advanced cervical cancer with para-aortic lymph node metastases treated with first-line tislelizumab plus bevacizumab combined with chemotherapy followed by radiotherapy with maintenance therapy: a case report
doi 10.3389/fimmu.2025.1573202
- 2,560 views
ORIGINAL RESEARCH
Published on 28 Apr 2025
The administration sequences of immune checkpoint inhibitors and chemotherapy cause discrete efficacy when treating non-small cell lung cancer: a retrospective study
doi 10.3389/fimmu.2025.1579420
- 1,844 views
- 2 citations
ORIGINAL RESEARCH
Published on 14 Apr 2025
Comparison of immunotherapy based total neoadjuvant therapy or standard neoadjuvant chemoradiation for locally advanced rectal cancer: a multi-institutional retrospective study
doi 10.3389/fimmu.2025.1513716
- 1,935 views
REVIEW
Published on 08 Apr 2025
Efficacy and safety of programmed cell death protein-1 inhibitor for first-line therapy of advanced gastric or gastroesophageal junction cancer: a network meta-analysis
doi 10.3389/fimmu.2025.1500954
- 2,923 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore